The Bull Case For Cohu (COHU) Could Change Following Upgraded 2026 HPC Outlook And AI Order Surge
Cohu, Inc. COHU | 0.00 |
- Cohu, Inc. reported past first-quarter 2026 results with sales of US$125.12 million and a net loss of US$12.07 million, while guiding second-quarter sales to about US$144 million plus or minus US$7 million.
- The company also highlighted a strong order surge linked to AI and high-performance computing demand, raising its 2026 HPC revenue outlook and underscoring the Eclipse platform’s growing role in next-generation data center and computing applications.
- We'll now examine how Cohu's upgraded 2026 HPC outlook and AI-driven order strength might reshape its existing investment narrative.
Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 31 best rare earth metal stocks of the very few that mine this essential strategic resource.
Cohu Investment Narrative Recap
To own Cohu today, you need to believe its AI and high performance computing positioning, particularly around Eclipse, can eventually translate strong orders into sustainable profits, despite current losses. The latest results and raised 2026 HPC outlook reinforce the near term catalyst of AI driven demand, but they also sharpen the biggest risk: execution and customer concentration around a handful of large HPC and data center programs.
The most relevant update here is Cohu’s April guidance that Q2 2026 sales should land around US$144 million, plus or minus US$7 million. This sits alongside management’s higher 2026 HPC revenue outlook of about US$80 million to US$100 million and a reported 57% year over year order increase, reinforcing that Eclipse and related AI and HPC wins are central to how quickly Cohu can move from recurring losses to a more balanced earnings profile.
Yet behind the AI order headlines, investors should be aware of...
Cohu's narrative projects $703.9 million revenue and $30.1 million earnings by 2029. This requires 15.8% yearly revenue growth and a $104.4 million earnings increase from -$74.3 million today.
Uncover how Cohu's forecasts yield a $35.50 fair value, a 22% downside to its current price.
Exploring Other Perspectives
Before this Q1 news, the most cautious analysts were assuming Cohu would reach about US$730 million in revenue and US$36.6 million in earnings by 2029, which is far more conservative than the AI and Eclipse driven opportunity you see today, so it is worth asking how those views might shift as new HPC orders come through.
Explore 2 other fair value estimates on Cohu - why the stock might be worth less than half the current price!
Reach Your Own Conclusion
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
- A great starting point for your Cohu research is our analysis highlighting 1 key reward and 1 important warning sign that could impact your investment decision.
- Our free Cohu research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Cohu's overall financial health at a glance.
Looking For Alternative Opportunities?
These stocks are moving-our analysis flagged them today. Act fast before the price catches up:
- AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
- We've uncovered the 13 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
- Invest in the nuclear renaissance through our list of 91 elite nuclear energy infrastructure plays powering the global AI revolution.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
